Thank you for attending our stand at ECVIM
At Dechra, we are committed to providing veterinarians with innovative tools and resources to improve animal health.
Below are details of some of our latest initiatives which may be of interest to you.
NEW: Dechra Endocrinology App
We are excited to announce the launch of our new endocrinology app, designed to help veterinarians better diagnose and treat endocrine disorders in their animal patients.
The app provides veterinarians with a prediction of how likely a dog is to have Cushing’s syndrome based on its clinical signs and supports effective diagnosis. With additional information on the treatment and monitoring of Cushing’s and Addison’s, the app helps veterinarians better understand endocrine disorders and stay up to date with the latest information provided by Dechra.The Dechra Endocrinology App is available for free download on both Apple and Android devices. Veterinarians can access the app's features and resources at any time, making it a convenient and valuable tool to have on hand.
Download now
NEW: Cushing's Connect
Dechra Veterinary Products is pleased to announce the launch of Cushing’s Connect. A one stop shop for everything you need to know about Cushing’s.
Cushing’s syndrome is one of the most commonly diagnosed endocrinopathies in dogs but, as cases are not always seen very regularly in general practice, it can be challenging for GP vets to know where to begin when diagnosing and managing these cases.
Cushing’s Connect is designed to help veterinarians better diagnose and treat endocrine disorders in their animal patients. It aims to help refresh their Cushing’s knowledge through four informative bitesize learning modules;
- Understanding Cushing’s
- Diagnosis
- Treatment & Monitoring
- Client Communication
The new website will also host an extensive library of learning resources providing vets with the confidence to successfully diagnose, treat and monitor Cushing's, as well as FAQs to help assist and refresh knowledge when it is needed the most.
To find out more visit Cushing's Connect
COMING SOON: Vetoryl Monitoring App for owners
The Vetoryl Monitoring App is a digital solution specially designed to aid dog owners in monitoring and managing Canine Cushing's syndrome. Recognising the challenges faced by dog owners in monitoring this complex disease, the Vetoryl Monitoring App aims to simplify, streamline, and enhance the management process.
Key features of the Vetoryl Monitoring App:
Daily Monitoring: Owners can effortlessly track their dog's daily symptoms, including appetite, water consumption, and energy levels.
Medication Reminders: Ensure timely administration of Vetoryl with customisable medication reminders.
Enhanced Collaboration: As owners monitor their dogs, you gain deeper insights. Understand each dog's condition more intimately for precise care.
To be the first to know more, register your interest here
Sedation has a new story
Sedation is an essential tool in every veterinary clinic. Effective sedation facilitates a range of procedures and treatments, allowing optimal and controlled patient care.
Introducing Zenalpha - Innovation in Canine Sedation
Zenalpha is an innovative combination of an alpha-2 agonist and a peripherally selective alpha-2 antagonist combination injection for dogs. Indicated for sedation to facilitate non-invasive, non-painful or mildly painful procedures intended to last less than 30 minutes.
With easy IM administration, fast onset of action (5-15 mins in most dogs) and short duration of action (around 45 mins in most dogs), Zenalpha is the ideal sedative for a wide range of procedures including imaging, blood sampling, ophthalmic examination, skin testing and many more. Heart rate and cardiac output are maintained within the physiological range and organ blood flow is well preserved providing better cardiovascular stability and easier patient monitoring. Zenalpha can be antagonised with atipamezole if desired, but this is not required routinely.
Zenalpha provides some much-needed calm to the sedation experience for patients, owners and your veterinary team.
Take control with Mirataz®
In a recent survey 80% of vets stated ease of administration as being the reason why they use Mirataz regularly1.
Mirataz is a licensed transdermal gel that has been specifically formulated for the treatment of weight loss in cats. It offers a practical solution for feline patients who struggle to consume oral medication due to a lack of appetite or other difficulties. With its ease of administration through topical application, Mirataz has proven to be an effective and well-received option by both veterinarians and cat owners
1. Dechra Internal Report – MZ 1222
Uraemic toxins – why should we be concerned?
The term uraemic toxins refers to substances that accumulate in the body when kidney function is impaired. The systemic effects of uraemic toxins are diverse and sometimes life-threatening.
Introducing Porus® One
Porus One helps bind protein byproducts in the intestines where they are excreted in the faeces.
This binding process helps to prevent the byproducts from being converted into uraemic toxins, which supports kidney health.
To find out more click here
